Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.9 USD | -1.15% | +0.64% | -7.15% |
Jun. 05 | Axsome Therapeutics Says It Settled Sunosi Patent Litigation With Unichem Laboratories | MT |
Jun. 05 | RBC Raises Price Target on Axsome Therapeutics to $130 From $127, Keeps Outperform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.15% | 3.51B | |
+0.82% | 91.94B | |
-1.32% | 38.74B | |
-12.88% | 32.82B | |
+64.32% | 26.66B | |
-16.31% | 15.32B | |
-11.38% | 11.65B | |
+173.10% | 10.37B | |
-49.84% | 10.12B | |
+3.90% | 9.06B |
- Stock Market
- Equities
- AXSM Stock
- News Axsome Therapeutics, Inc.
- Guggenheim Adjusts Price Target on Axsome Therapeutics to $100 From $90, Maintains Buy Rating